Mineralys Therapeutics In... (MLYS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
9.54
0.42 (4.61%)
At close: Jan 15, 2025, 9:49 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a |
Operating Income | -84.66M | -31.48M | -18.73M | -2.94M |
Interest Income | 12.76M | 1.68M | n/a | n/a |
Pretax Income | -71.90M | -29.80M | -19.41M | -3.43M |
Net Income | -71.90M | -29.80M | -19.41M | -3.43M |
Selling & General & Admin | 14.30M | 5.23M | 2.42M | 532.00K |
Research & Development | 70.36M | 26.25M | 16.31M | 2.41M |
Other Expenses | n/a | 4.00K | 1K | -1K |
Operating Expenses | 84.66M | 31.48M | 18.73M | 2.94M |
Interest Expense | n/a | 1.68M | 27.00K | 115.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 84.66M | 31.48M | 18.73M | 2.94M |
Income Tax | n/a | -1.90M | 27.00K | 115.00K |
Shares Outstanding (Basic) | 36.19M | 40.86M | 39.06M | 39.06M |
Shares Outstanding (Diluted) | 36.19M | 40.86M | 39.06M | 39.06M |
EPS (Basic) | -1.99 | -0.73 | -0.5 | -0.09 |
EPS (Diluted) | -1.99 | -0.73 | -0.5 | -0.09 |
EBITDA | -84.66M | -31.48M | n/a | n/a |
Depreciation & Amortization | n/a | 228.49K | 18.73M | 2.94M |